LCTX
Lineage Cell Therapeutics, Inc.Company with tickers: LCTX
CIK
876343
CUSIP
53566P109
Shares Outstanding
249,298,295
13F Activity (30d)
113 filings
113 filers
Price
$1.29
Market Cap
$324.09M
P/E Ratio
-4.59
EPS (Diluted)
$-0.28
52W High
$2.09
52W Low
$0.50
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $1,725,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Revenue (ASC 606) | $1,725,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $4,234,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-7,593,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-4,812,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.03 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |